Zobrazeno 1 - 10
of 12
pro vyhledávání: '"B. H. Schmidt"'
Autor:
B. H. Schmidt, C.G. van Reenen, J. de Groot, F.J. van der Staay, A. H. Hoving-Bolink, T. Schuurman
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 5
Journal of Veterinary Pharmacology and Therapeutics, 30(5), 410-416
Journal of Veterinary Pharmacology and Therapeutics, 30(5), 410-416
We assessed the efficacy of Butafosfan, a component of Catosal®, in the metaphylactic treatment of stress in pigs. Four 6-week-old female littermates were taken from 12 litters. They were confronted with a pig from a different litter for 2 h. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12f51300290349b0be85b8638e8e0e7
https://research.wur.nl/en/publications/effects-of-butafosfan-on-salivary-cortisol-and-behavioral-respons
https://research.wur.nl/en/publications/effects-of-butafosfan-on-salivary-cortisol-and-behavioral-respons
Publikováno v:
Neurochemical research. 24(8)
In previous metrifonate (MTF) studies, there has been evidence for a preferential functional effect of the drug in cortical but not in striatal regions. In the present study we investigated the kinetics of brain cholinesterase (ChE) inhibition follow
Publikováno v:
Neurochemical research. 23(7)
The effects of subchronic oral administration of metrifonate, a long-acting cholinesterase (ChE) inhibitor, on cholinergic neurotransmission were assessed in young adult male Wistar rats. Animals were treated twice daily with metrifonate. In a pilot
Autor:
U. Spiecker-Hauser, B. H. Schmidt
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 29:207-208
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 278(2)
Metrifonate is currently under development as a putative cholinergic Alzheimer therapeutic, because it is a prodrug of the long-acting organophosphate cholinesterase (ChE) inhibitor dichlorvos. The aim of this study was to examine whether the transfo
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 14(10)
In order to characterize the interaction site of a series of putative calmodulin antagonists of the diphenylalkylamine type with calmodulin (CaM), a representative member of this chemical class was radiolabelled. The binding of the selected compound,
Autor:
B. H. Schmidt, M. Beneke, R. Horstmann, W. Wingender, H. Weber, J. Kuhlmann, I. Konrad-Dalhoff
Publikováno v:
European journal of clinical pharmacology. 42(2)
The neuroendocrine effects (changes in plasma CRF, ACTH and cortisol) of single and multiple (t.d.s. for 2 days) doses of ipsapirone (BAY Q 7821) 5 and 10 mg have been investigated in 6 healthy male volunteers. The study followed a balanced complete
Autor:
B H, Schmidt, J E, Schultz
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 233(2)
Treatment of Sprague-Dawley rats for 9 days with 15 micrograms/kg of tri-iodo-thyronine, 50 micrograms/kg of thyroxine (T4) or 500 micrograms/kg of thyrotropin-releasing hormone decreased the number of beta receptors in cerebral cortex as measured by
Publikováno v:
Molecular pharmacology. 32(3)
Glutamate is able to stimulate inositol phosphate (IP) formation in striatal neurons in primary culture, mainly via an excitatory amino acid receptor of the quisqualate subtype. In the present study we show that carbachol (Carb)-(a cholinergic agonis
Autor:
B. H. Schmidt, Kurt Mehlhorn
Publikováno v:
Foundations of Computation Theory ISBN: 9783540126898
We show how to solve a single source shortest path problem on a planar network in time O(n3/2log n). The algorithm works for arbitrary edge weights (positive and negative) and is based on the planar separator theorem. More generally, the algorithm wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb180d95d4ee4c0e1b3ca025fcc41018
https://doi.org/10.1007/3-540-12689-9_113
https://doi.org/10.1007/3-540-12689-9_113